1,064 results on '"Hojsak, Iva"'
Search Results
2. Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
3. Impact of an exercise program in children with inflammatory bowel disease in remission
4. Children with inflammatory bowel disease already have an altered arterial pulse wave
5. Correction: Impact of an exercise program in children with inflammatory bowel disease in remission
6. Helicobacter Pylori Gastritis and Peptic Ulcer Disease
7. Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease
8. Drugs in focus: Botulinum toxin in the therapy of gastrointestinal disorders in children.
9. Volumetric Analysis of Motor Cortex and Basal Ganglia in Pediatric Celiac Disease Patients Using volBrain: Implications for Neurological Dysfunction-Preliminary Results.
10. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
11. Importance of dietary fiber in children.
12. A pilot case-control study on the fecal microbiota of pediatric functional abdominal pain-not otherwise specified and the role of early life stress
13. Nutritional Outcomes of Bowel Lengthening Procedure in Patients with Short Bowel Syndrome
14. Synbiotics in the Management of Pediatric Gastrointestinal Disorders: Position Paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications
15. 1.3.4 Digestible and Non-Digestible Carbohydrates
16. Postupnik za procjenu i liječenje gastroezofagealne refluksne bolesti u dječjoj dobi – smjernice Hrvatskog društva za pedijatrijsku gastroenterologiju, hepatologiju i prehranu Hrvatskoga liječničkog zbora
17. Reevaluating the FDA's warning against the use of probiotics in preterm neonates : a societal statement by ESPGHAN and EFCNI
18. Helicobacter Pylori Gastritis and Peptic Ulcer Disease
19. Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children.
20. Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study.
21. Probiotics in Functional Gastrointestinal Disorders
22. Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: Results of the double-blind randomized study
23. Malnourished children acquire nosocomial infections more often and have significantly increased length of hospital stay
24. Characteristics of polymeric formula and route of delivery of exclusive enteral nutrition have no effect on disease outcome and weight gain in pediatric Crohn's disease
25. An Almost Herbst’s Triad: Finger Clubbing and Iron Deficiency Anemia Associated With Severe Gastroesophageal Reflux
26. Role of Probiotics in the Treatment and Prevention of Common Gastrointestinal Conditions in Children
27. Use of probiotics in the treatment of functional abdominal pain in children—systematic review and meta-analysis
28. IBD phenotype at diagnosis, and early disease-course in pediatric patients in Croatia: data from the Croatian national registry
29. Nutritional status and its effect on complications in patients with colorectal cancer
30. Pediatric Endoscopy Quality Improvement Network Pediatric Endoscopy Reporting Elements: A Joint NASPGHAN/ESPGHAN Guideline
31. Pediatric Endoscopy Quality Improvement Network Quality Standards and Indicators for Pediatric Endoscopists and Endoscopists in Training: A Joint NASPGHAN/ESPGHAN Guideline
32. Overview of the Pediatric Endoscopy Quality Improvement Network Quality Standards and Indicators for Pediatric Endoscopy: A Joint NASPGHAN/ESPGHAN Guideline
33. Pediatric Endoscopy Quality Improvement Network Quality Standards and Indicators for Pediatric Endoscopic Procedures: A Joint NASPGHAN/ESPGHAN Guideline
34. Pediatric Endoscopy Quality Improvement Network Quality Standards and Indicators for Pediatric Endoscopy Facilities: A Joint NASPGHAN/ESPGHAN Guideline
35. Clinical Features and Outcomes of Paediatric Patients With Isolated Colonic Crohn Disease
36. Moderate-to-Vigorous Physical Activity Is Associated With Higher Bone Mineral Density in Children With Inflammatory Bowel Disease
37. Diagnostic Utility of pH-MII Monitoring in Preschool Children with Recurrent Wheeze and Suspected Gastroesophageal Reflux Disease: A Prospective Study
38. The Frequency and Impact of Self-Imposed Elimination Diets on the Nutritional Status and Clinical Course of Disease in Children with Inflammatory Bowel Disease
39. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Complications
40. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Fluid and electrolytes
41. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Organisational aspects
42. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Standard versus individualized parenteral nutrition
43. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Venous access
44. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Home parenteral nutrition
45. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids
46. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Guideline development process for the updated guidelines
47. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Amino acids
48. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy
49. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Iron and trace minerals
50. Percutaneous Endoscopic Gastrostomy in Children: An Update to the ESPGHAN Position Paper
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.